PA Turnpike tollbooths removed at interchanges
(WBRE/WYOU) — Multiple tollbooths have been removed from the Pennsylvania Turnpike in areas where Open Road Tolling (ORT) has begun.
The PA Turnpike has started removing toll plazas along the turnpike, starting with the Pocono Interchange (Exit 95) and on the Northeast Extension (Interstate 476), with plans to remove all tollbooths by 2028.
The two tollbooths have been removed where the ORT system has launched. The ORT system will have gantries above the turnpike that allow for unobstructed traffic flow. You will be able to drive highway speeds through the ORT gantries.
Death investigation underway in Williamsport
'The PA Turnpike has been a leader in transportation from the day we opened in 1940 as 'America's First Superhighway' and while traditional tollbooths made practical sense then, we now have more advanced and efficient systems that better serve today's 21st century customers… The switch to ORT modernizes the Pennsylvania Turnpike for today. We look forward to providing customers with a safer and more convenient travel experience on the PA Turnpike and better serving the communities we touch along the way.'
PA Turnpike CEO Mark Compton
The ORT gantries charge the driver by E-ZPass or by Toll By Plate.
The switch to ORT in the east of the state occurred in January and will launch in the turnpike's west section in 2027. The PA Turnpike Commission says the tollbooths on the mainline will be fully removed across the turnpike by the end of 2028.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Repairs begin on Blue Bridge in Owensboro
OWENSBORO, Ky. (WEHT) — Lane restrictions are underway on the Blue Bridge in Owensboro. This is the first phase of repairs that are set to begin after the fourth of July holiday weekend. Currently one lane of Kentucky 2262 will remain open during this initial part of the work which will include flaggers directing alternating one-lane traffic. After the 4th of July the bridge will be completely closed for 90 days this summer. During the closure crews will replace the aging bridge deck, make concrete repairs and repair bridge joints. Officials say only closing one lane at a time is impossible, requiring the bridge to close completely. The repairs will allow for long-term concrete maintenance to be completed helping to keep the bridge safe and open for years to come. The lane restrictions should end June 12th before being closed for 90 days. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
U.S. 41 lanes to re-open as ramps with Lloyd Expressway close
EVANSVILLE, Ind. (WEHT) – A stretch of Highway 41 that has been closed and under construction for months will finally see traffic next week. At the same time, drivers will have to navigate new closures near Highway 41 and the Lloyd Expressway. The southbound lanes of Highway 41 between Diamond Avenue and the Lloyd will reopen on or around June 17, but traffic in both directions will still be down to two lanes as crews continue their work. INDOT also says drivers will be able to turn left all along southbound 41. Also on June 17, the approach to U.S. 41 from Virginia Street will re-open to drivers as crews have resurfaced the area and reconstructed the sidewalks. Drive Clean Indiana eyeing Evansville as its next big E-V charging hub A 3-week closure is set for the ramp from southbound 41 to the westbound Lloyd, with the southbound 41 on-ramp from the westbound Lloyd to close for 2 weeks. Gary Brian with INDOT says this is part of a larger re-construction up and down the highway. 'This has been a stretch of roadway that has needed work for years,' says Brian. 'We know, I think anybody who has driven through Evansville. I knew driving through Evansville, right, that there were areas that were rough, that needed a complete reconstruction. So, you know, every road has its lifespan, and this stretch of 41 had reached the end of its lifespan.' The dates and the construction timeline are weather-permitting. Brian says the entire Highway 41 re-construction should be wrapped up later this Fall. You can read about the full breakdown of these re-openings and closures by clicking here. U.S. 41 lanes to re-open as ramps with Lloyd Expressway close Shawnee farmers plant historic corn at Angel Mounds What's the buzz? USI professor brings beekeeping passion to campus U.S. Veterans Affairs secretary tours Evansville clinic Where are they on that project: The Vault on Main Eyewitness News. Everywhere you are. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy rating and a price objective of $65. A scientist holding a vial of a promising product candidate for therapeutic development. The rating is part of a larger biotech sector note, in which the firm sees favorable risk/reward across the board. Raymond James points out that less de-risked platforms can produce the most outsized returns, even if companies with de-risked, high probability-of-success assets are frequently viewed with greater certainty. The firm stresses its confidence in del-zota, which is anticipated to be the first medicine from Avidity Biosciences, Inc. (NASDAQ:RNA)'s antibody oligonucleotide conjugate (AOC) platform to be approved. Avidity Biosciences, Inc. (NASDAQ:RNA) is becoming more well-known for its AOC platform, which targets muscle disorders by combining oligonucleotides and antibodies. According to Raymond James, one of the platform's top candidates, Del-Zota, has a strong chance of being approved. The $65 objective is in line with the firm's opinion that early-stage, less-risked assets can yield higher returns and points out faith in the platform's revolutionary potential. Avidity Biosciences, Inc. (NASDAQ:RNA) is a biopharmaceutical firm dedicated to developing a novel type of RNA treatment known as Antibody Oligonucleotide Conjugates, or AOCs. While we acknowledge the potential of RNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.
